Mehmet GÜL, Mustafa Kemal EROL, Hüseyin UYAREL, Aydın YILDIRIM, Nevzat USLU, Abdurrahman EKSİK, İhsan BAKIR, Mehmet ERTÜRK, Özgür SÜRGİT

The outcomes of transcatheter aortic valve implantation with Edwards SAPIEN or CoreValve devices: Single-center experience in Turkey

Amaç: Bu çalışmada transkateter aort kapak implantasyonunun erken ve orta dönem sonuçları değerlendirildi. Çalışma planı: Ekim 2010 - Şubat 2012 tarihleri arasında kliniğimizde transkateter aort kapak implantasyonu yapılan, cerrahi riski yüksek (EuroSCORE 26.0±9.9) 35 hasta (16 erkek, 19 kadın; ort. yaş 77.4±6.9 yıl; dağılım 58-91 yıl) çalışmaya dahil edildi. Edwards SAPIEN (n=27) ve CoreValve protezler (n=8) transfemoral (n=33), transapikal (n=1), subklavian (n=1) yaklaşım ile yerleştirildi. Hastaların işlem öncesi ekokardiyografik ortalama kapak alanı 0.6±0.1 cm2, ortalama transvalvüler gradiyent 53.3±8.0 mmHg idi. Bulgular: İşlemin başarı oranı %97 idi. İşlem sonrasında ortalama transvalvüler gradiyent 9.8±2.7 mmHg’ye gerilerken (p

Edwards SAPIEN ve CoreValve cihazlar ile transkateter aort kapak implantasyonu sonuçları: Türkiye’den tek merkezli deneyim

Background: This study aims to evaluate early- and midterm outcomes of transcatheter aortic valve implantation. Methods: Between October 2010 and February 2012, 35 patients (16 males, 19 females; mean age 77.4±6.9 years; range 58 to 91 years) who were at high risk for surgery (EuroSCORE 26.0±9.9) and underwent transcatheter aortic valve implantation in our clinic were included. Edwards SAPIEN (n=27) and CoreValve prostheses (n=8) were implanted by transfemoral (n=33), transapical (n=1), and subclavian (n=1) approaches. The mean preoperative echocardiographic valve area was 0.6±0.1 cm2, while the mean transvalvular gradient was 53.3±8.0 mmHg. Results: The procedural success rate was 97%. Following the procedure, the mean transvalvular gradient decreased to 9.8±2.7 mmHg, whereas the average aortic valve area increased to 1.9±0.2 cm2. The mean NYHA functional capacity reduced from 3.5±0.5 before the procedure to 1.4±0.6 at three months during follow-up (p

PDF

___

1. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008;118:e523-661.
2. O’Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2-isolated valve surgery. Ann Thorac Surg 2009;88(1 Suppl):S23-42.
3. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005;26:2714-20.
4. Culliford AT, Galloway AC, Colvin SB, Grossi EA, Baumann FG, Esposito R, et al. Aortic valve replacement for aortic stenosis in persons aged 80 years and over. Am J Cardiol 1991;67:1256-60.
5. Lieberman EB, Bashore TM, Hermiller JB, Wilson JS, Pieper KS, Keeler GP, et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. J Am Coll Cardiol 1995;26:1522-8.
6. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the secondand current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76.
7. Roques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE. Eur Heart J 2003;24:881-2.
8. Edwards FH, Grover FL, Shroyer AL, Schwartz M, Bero J. The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. Ann Thorac Surg 1997;63:903-8.
9. Yücel G, Paker T, Akçevin A, Sezer A, Eryilmaz A, Ozyiğit T, et al. Transcatheter aortic valve implantation: the first applications and early results in Turkey. [Article in Turkish] Turk Kardiyol Dern Ars 2010;38:258-63.
10. Dagdelen S, Karabulut H, Senay S, Akyol A, Toraman F, Cagıl, et al. Transcatheter aortic valve implantation in patients with high-risk aortic stenosis: a clinical follow-up. Turk Gogus Kalp Dama 2011;19:495-502.
11. Zajarias A, Cribier AG. Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol 2009;53:1829-36.
12. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116:755-63.
13. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842-50.
14. Zegdi R, Ciobotaru V, Noghin M, Sleilaty G, Lafont A, Latrémouille C, et al. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. J Am Coll Cardiol 2008;51:579-84.
15. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8.
16. Svensson LG, Dewey T, Kapadia S, Roselli EE, Stewart A, Williams M, et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 2008;86:46-54.
17. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006;47:1214-23.
18. Walther T, Simon P, Dewey T, Wimmer-Greinecker G, Falk V, Kasimir MT, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007;116(11 Suppl):I240-5.
19. Eltchaninoff H, Tron C, Bauer F, Brunet D, Baala B, Drogoul L, et al. Aortic bioprosthesis implanted percutaneously: three year follow up. Arch Mal Coeur Vaiss 2007;100:901, 904-8. [Abstract]
20. Gül M, Türen S, Sürgit O, Aksu HU, Uslu N. Acute severe occlusion of the left main coronary artery following transcatheter aortic valve implantation. Anadolu Kardiyol Derg 2012;12:282-3. doi: 10.5152/akd.2012.082.
21. Dawkins S, Hobson AR, Kalra PR, Tang AT, Monro JL, Dawkins KD. Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictors. Ann Thorac Surg 2008;85:108-12.
22. Sinhal A, Altwegg L, Pasupati S, Humphries KH, Allard M, Martin P, et al. Atrioventricular block after transcatheter balloon expandable aortic valve implantation. JACC Cardiovasc Interv 2008;1:305-9.
23. Piazza N, Onuma Y, Jesserun E, Kint PP, Maugenest AM, Anderson RH, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv 2008;1:310-6.
24. Eltchaninoff H, Zajarias A, Tron C, Litzler PY, Baala B, Godin M, et al. Transcatheter aortic valve implantation: technical aspects, results and indications. Arch Cardiovasc Dis 2008;101:126-32.
25. Grube E, Ulrich G, Schuler G, Linke A, Bonan R, Serruys PW, et al. Experience with Corevalve aortic valve replacement in patients for surgical aortic valve replacement. J Am Coll Cardiol Intv 2008;(Suppl B):21
26. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011;123:299-308.
27. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.